Top Markets
Coin of the day
Anthera Pharmaceuticals, Inc. Anthera Pharmaceuticals, Inc.

Anthera Pharmaceuticals, Inc.

ANTH
शेयरों में रैंक #42276
Anthera Pharmaceuticals, Inc., a biopharmaceutical enterprise, concentrates on... Anthera Pharmaceuticals, Inc., a biopharmaceutical enterprise, concentrates on developing and commercializing therapeutic solutions for conditions with significant unmet medical needs. The company's pipeline includes Sollpura, an investigational non-porcine pancreatic enzyme replacement therapy in Phase III clinical trials for individuals with exocrine pancreatic insufficiency. It is also advancing Blisibimod, currently in Phase II clinical evaluation for B-cell mediated autoimmune diseases, such as immunoglobulin A nephropathy (IgA nephropathy). Anthera holds licensing agreements with Amgen, Inc. and Eli Lilly and Company. Founded in 2004, the company's base of operations is in Houston, Texas.
शेयर मूल्य
$0.0001
अंतिम समन्वयन: 2026-08-11
मार्केट कैप
$2.62K
बदलाव (1 दिन)
0.00%
बदलाव (1 वर्ष)
0.00%
देश
US
व्यापार Anthera Pharmaceuticals, Inc. (ANTH)

श्रेणी

Anthera Pharmaceuticals, Inc. (ANTH) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $0.00 (2026-08-01 को)

दिन का सबसे निम्न समापन मूल्य: $450.76 (2010-03-01 को)
Anthera Pharmaceuticals, Inc. के स्टॉक मूल्य का इतिहास 2010 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2026 (TTM) 0.00%
2025 -18.71%
2024 -4.67%
2023 0.00%
2022 -15.38%
2021 -99.38%
2020 -48.36%
2019 -0.60%
2018 -97.65%
2017 -88.08%
2016 -65.41%
2015 166.78%
2014 -38.48%
2013 -45.84%
2012 -89.34%
2011 26.69%
2010 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
$527.87 33.33%
US
$873.57 35.10%
NL
$742.88 8.64%
CH
$1.08K -6.68%
KR
$261.43 17.34%
BE